You can:
Name | Somatostatin receptor type 1 |
---|---|
Species | Homo sapiens (Human) |
Gene | SSTR1 |
Synonym | SRIF-2 SS-1-R SS1-R SS1R SST1 receptor |
Disease | Alzheimer disease Cushing's disease Neuroendocrine cancer |
Length | 391 |
Amino acid sequence | MFPNGTASSPSSSPSPSPGSCGEGGGSRGPGAGAADGMEEPGRNASQNGTLSEGQGSAILISFIYSVVCLVGLCGNSMVIYVILRYAKMKTATNIYILNLAIADELLMLSVPFLVTSTLLRHWPFGALLCRLVLSVDAVNMFTSIYCLTVLSVDRYVAVVHPIKAARYRRPTVAKVVNLGVWVLSLLVILPIVVFSRTAANSDGTVACNMLMPEPAQRWLVGFVLYTFLMGFLLPVGAICLCYVLIIAKMRMVALKAGWQQRKRSERKITLMVMMVVMVFVICWMPFYVVQLVNVFAEQDDATVSQLSVILGYANSCANPILYGFLSDNFKRSFQRILCLSWMDNAAEEPVDYYATALKSRAYSVEDFQPENLESGGVFRNGTCTSRITTL |
UniProt | P30872 |
Protein Data Bank | N/A |
GPCR-HGmod model | P30872 |
3D structure model | This predicted structure model is from GPCR-EXP P30872. |
BioLiP | N/A |
Therapeutic Target Database | T16633 |
ChEMBL | CHEMBL1917 |
IUPHAR | 355 |
DrugBank | BE0000452 |
Name | CHEMBL442605 |
---|---|
Molecular formula | C28H35N5O3 |
IUPAC name | (2S)-2-[(4R)-4-acetamido-3-oxo-1,4,5,10-tetrahydroazepino[3,4-b]indol-2-yl]-6-amino-N-(2-phenylethyl)hexanamide |
Molecular weight | 489.62 |
Hydrogen bond acceptor | 4 |
Hydrogen bond donor | 4 |
XlogP | 2.3 |
Synonyms | BDBM50254259 (5S)-5-[(4R)-4-(acetylamino)-3-oxo-3,4,5,10-tetrahydroazepino[3,4-b]indol-2(1H)-yl]-6-oxo-6-[(2-phenylethyl)amino]hexan-1-aminium trifluoroacetate CHEMBL1185941 |
Inchi Key | BZBKOTKAPXOMFC-RSXGOPAZSA-N |
Inchi ID | InChI=1S/C28H35N5O3/c1-19(34)31-24-17-22-21-11-5-6-12-23(21)32-25(22)18-33(28(24)36)26(13-7-8-15-29)27(35)30-16-14-20-9-3-2-4-10-20/h2-6,9-12,24,26,32H,7-8,13-18,29H2,1H3,(H,30,35)(H,31,34)/t24-,26+/m1/s1 |
PubChem CID | 25188780 |
ChEMBL | N/A |
IUPHAR | N/A |
BindingDB | 50254259 |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand satisfies Lipinski's rule of five. |
Parameter | Value | Reference | Database source |
---|---|---|---|
IC50 | 105.0 nM | PMID19067538 | BindingDB |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417